Actinium Announces Notice of Allowance for U.S. Patent Related to Actimab-A
November 14, 2016 07:00 ET
|
Actinium Pharmaceuticals
Allowed patent application claims method for purifying actinium-225 NEW YORK, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a...
Actinium Pharmaceuticals Announces Key Hire in Clinical Supply Chain Organization as Company Expands To Accommodate Continued Growth
October 31, 2016 07:00 ET
|
Actinium Pharmaceuticals
- Incoming Industry Veteran to Lead Clinical Supply Chain Operations and Architect the Build Out of the Anticipated Commercial Supply Chain NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Actinium...
Actinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual Meeting
October 19, 2016 07:00 ET
|
Actinium Pharmaceuticals
NEW YORK, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B
October 18, 2016 07:00 ET
|
Actinium Pharmaceuticals
- Orphan designation is expected to provide increased communication and guidance from regulators and 10-year market exclusivity should marketing authorization be obtained - Orphan designation...
Actinium Announces Closing of Public Offering of Common Stock
October 04, 2016 16:15 ET
|
Actinium Pharmaceuticals
NEW YORK, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Pricing of Public Offering of Common Stock
September 29, 2016 08:15 ET
|
Actinium Pharmaceuticals
NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60
September 27, 2016 07:00 ET
|
Actinium Pharmaceuticals
Webinar to be held at 9:00 AM ET to highlight Actimab-A Phase 2 clinical trial and protocol revisions agreed to by the FDAProtocol revisions agreed to by the FDA include the use of peripheral blast...
Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial
September 21, 2016 08:00 ET
|
Actinium Pharmaceuticals
- Webinar to be Held on Tuesday, September 27, 2016 at 9:00 AM ET - Webinar to feature Principle Investigator Joseph Jurcic, M.D., Professor of Clinical Medicine and Director of the Hematologic...
Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial
September 20, 2016 07:00 ET
|
Actinium Pharmaceuticals
NEW YORK, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference
September 19, 2016 07:00 ET
|
Actinium Pharmaceuticals
- Actinium to Present on Tuesday, September 27, 2016 at 1:00 PM ET - Management Will be Available for 1-on-1 Meetings with Conference Attendees NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) --...